News
Market Data
Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
The current EMV market cap is 161.45M. The company's latest EPS is AUD -0.0320 and P/E is -58.75.
| Year End June 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Revenue | 1.6M | 1.75M | 4.36M | 6.97M | 11.22M |
| Operating Income | -3.51M | -8.44M | -6.11M | -3.96M | -2.26M |
| Net Income | -3.48M | -8.4M | -6.11M | -3.87M | -2.73M |
| Year End June 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Assets | 6.01M | 10.77M | 8.51M | 11.52M | 23.97M |
| Total Liabilities | 490k | 720k | 1.43M | 6.4M | 5.46M |
| Total Equity | 5.52M | 10.05M | 7.08M | 5.12M | 18.52M |
| Year End June 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Operating | -3.26M | -4.5M | -3.78M | 834k | -5.99M |
| Investing | N/A | -127k | -191k | -187k | -302k |
| Financing | 4.28M | 8.9M | 1.08M | 2.52M | 15M |
| Market Cap | 161.45M |
| Price to Earnings Ratio | -58.75 |
| Price to Sales Ratio | 14.32 |
| Price to Cash Ratio | 8.63 |
| Price to Book Ratio | 8.67 |
| Dividend Yield | - |
| Shares Outstanding | 85.42M |
| Average Volume (1 week) | 21.65k |
| Average Volume (1 Month) | 20.51k |
| 52 Week Change | -7.80% |
| 52 Week High | 2.72 |
| 52 Week Low | 1.75 |
| Spread (Intraday) | 0.02 (1.06%) |
| Company Name | EMvision Medical Devices Limited |
| Address |
level 10, 12 creek street brisbane, queensland 4000 |
| Website | https://www.emvision.com.au |
| Industry | ortho,prosth,surg appl,suply (3842) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
